These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19514643)

  • 1. Iatrogenic hyperkalemia as a serious problem in therapy of cardiovascular diseases in elderly patients.
    Wozakowska-Kapłon B; Janowska-Molenda I
    Pol Arch Med Wewn; 2009 Mar; 119(3):141-7. PubMed ID: 19514643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of factors causing hyperkalemia.
    Takaichi K; Takemoto F; Ubara Y; Mori Y
    Intern Med; 2007; 46(12):823-9. PubMed ID: 17575373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.
    Khosla N; Kalaitzidis R; Bakris GL
    Am J Nephrol; 2009; 30(5):418-24. PubMed ID: 19738369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases.
    Schepkens H; Vanholder R; Billiouw JM; Lameire N
    Am J Med; 2001 Apr; 110(6):438-41. PubMed ID: 11331054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum potassium in stage 5 CKD patients on their first presentation in a dialysis service of a county hospital in western Romania.
    Gluhovschi G; Mateş A; Gluhovschi C; Golea O; Gădălean F; Somai M; Ene I; Petrica L; Velciov S
    Rom J Intern Med; 2014; 52(1):30-8. PubMed ID: 25000676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR; Rolfe M
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):531-48. PubMed ID: 20150448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.
    Antoniou T; Gomes T; Juurlink DN; Loutfy MR; Glazier RH; Mamdani MM
    Arch Intern Med; 2010 Jun; 170(12):1045-9. PubMed ID: 20585070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy.
    Muzzarelli S; Maeder MT; Toggweiler S; Rickli H; Nietlispach F; Julius B; Burkard T; Pfisterer ME; Brunner-La Rocca HP;
    Am J Cardiol; 2012 Mar; 109(5):693-8. PubMed ID: 22152974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrolyte abnormalities and metabolic acidosis in two Duchenne muscular dystrophy patients with advanced congestive heart failure].
    Matsumura T; Saito T; Miyai I; Nozaki S; Kang J
    Rinsho Shinkeigaku; 2000 May; 40(5):439-45. PubMed ID: 11002725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-acquired hyperkalemia in elderly patients: risk factors and clinical outcomes.
    Turgutalp K; Bardak S; Helvacı I; İşgüzar G; Payas E; Demir S; Kıykım A
    Ren Fail; 2016 Oct; 38(9):1405-1412. PubMed ID: 27494301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperkalemia and renal function during monotherapy and dual renin-angiotensin blockade in the community setting.
    Kurnik D; Vesterman-Landes J; Bialik M; Katzir I; Lomnicky Y; Halkin H; Loebstein R
    Clin Ther; 2011 Apr; 33(4):456-64. PubMed ID: 21635991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program.
    Desai AS; Swedberg K; McMurray JJ; Granger CB; Yusuf S; Young JB; Dunlap ME; Solomon SD; Hainer JW; Olofsson B; Michelson EL; Pfeffer MA;
    J Am Coll Cardiol; 2007 Nov; 50(20):1959-66. PubMed ID: 17996561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on serum potassium levels and renal function in ambulatory outpatients: risk factors analysis.
    Maddirala S; Khan A; Vincent A; Lau K
    Am J Med Sci; 2008 Oct; 336(4):330-5. PubMed ID: 18854676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical factors associated with hyperkalemia in patients with congestive heart failure.
    Ramadan FH; Masoodi N; El-Solh AA
    J Clin Pharm Ther; 2005 Jun; 30(3):233-9. PubMed ID: 15896240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the concurrent use of potassium-influencing drugs as risk factors for the development of hyperkalemia.
    Kuijvenhoven MA; Haak EA; Gombert-Handoko KB; Crul M
    Int J Clin Pharm; 2013 Dec; 35(6):1099-104. PubMed ID: 23974985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW; Won YW; Yi JH; Kim HJ
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk for hyperkalemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the glomerular filtration rate].
    Raml A; Schmekal B; Grafinger P; Biesenbach G
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1327-30. PubMed ID: 11719857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals.
    Noize P; Bagheri H; Durrieu G; Haramburu F; Moore N; Giraud P; Galinier M; Pourrat J; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):747-53. PubMed ID: 21438068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.